Merli Saare - Gynecology

Author Information

Merli Saare is affiliated with the Competence Centre on Health Technologies Tartu, Estonia, and the Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. She has made significant contributions to the field of gynecology, particularly focusing on endometrial receptivity, in vitro fertilization failure, and endometriosis.

Research Contributions

Merli Saare has made substantial contributions to the study of endometrial receptivity and related conditions. Her research delves into the molecular and microbial profiles associated with endometrial health, IVF outcomes, and endometriosis. Notable papers include studies on the differences in microbial profiles in IVF failure, miR/isomiR expression dynamics, and potential innate immunity-related markers for endometrial receptivity. Her work has provided crucial insights into the molecular layers of endometrial receptivity and has explored innovative targeting mechanisms for endometriosis.

Aliases

Merli Saare is also known by the following aliases: M Saare and M. Saare.

Publication and Citation Metrics

Metric	Value
Citation Count	1240
H-index	18
Paper Count	49

Publications:

Differences in microbial profile of endometrial fluid and tissue samples in women with in vitro fertilization failure are driven by Lactobacillus abundance

DOI: 10.1111/aogs.14297

Year: 2022

P–290 Time-course analysis of endometrial miR/isomiR expression dynamics during hCG-primed menstrual-cycle phase transitions

DOI: 10.1093/humrep/deab130.289

Year: 2021

Potential innate immunity-related markers of endometrial receptivity and recurrent implantation failure (RIF).

DOI: 10.1016/j.repbio.2021.100569

Year: 2021

Coupling miR/isomiR and mRNA Expression Signatures Unveils New Molecular Layers of Endometrial Receptivity

DOI: 10.3390/life11121391

Year: 2021

Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis

DOI: 10.3390/nano11123257

Year: 2021

Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis.

DOI: 10.1093/humrep/deaa164

Year: 2020

A molecular tool for menstrual cycle phase dating of endometrial samples in endometriosis transcriptome studies†

DOI: 10.1093/biolre/ioz092

Year: 2019

A molecular tool for menstrual cycle phase dating of endometrial samples in endometriosis transcriptome studies†

DOI: 10.1093/biolre/ioz072

Year: 2019

MUC20 expression marks the receptive phase of the human endometrium.

DOI: 10.1016/J.RBMO.2019.05.004

Year: 2019

58 SYNDECAN-1 Inhibition reverses the pre-malignant phenotype of endometrioma through TGF-BETA signalling: potential implications in endometriosis associated ovarian cancer

DOI: 10.1136/ijgc-2019-IGCS.58

Year: 2019

How are Antibiotics Chosen for Treatment?

What is the Laid Back Position?

Why are Regular Gynecological Check-ups Important?

How Does Hydration Impact Gynecological Health?

How is AMH Measured?

How is CGG Repeat Testing Conducted?

Why are Medication Adjustments Necessary?

When to Start Pelvic Floor Exercises?

Are Douches and Feminine Sprays Safe?

Are There Alternatives to SSRIs?

Partnered Content Networks

Relevant Topics